Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation.
- DOI
- 10.1136/heartjnl-2021-319321
- Published
- 2021 Nov
- Container
- Heart (British Cardiac Society)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/heartjnl-2021-319321,
title = {Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation.},
author = {Fukaya H and Ako J and Yasuda S and Kaikita K and Akao M and Matoba T and Nakamra M and Miyauchi K and Hagiwara N and Kimura K and Hirayama A and Matsui K and Ogawa H},
year = {2021},
journal = {Heart (British Cardiac Society)},
doi = {10.1136/heartjnl-2021-319321},
url = {https://doi.org/10.1136/heartjnl-2021-319321}
}RIS
TY - JOUR TI - Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation. AU - Fukaya H AU - Ako J AU - Yasuda S AU - Kaikita K AU - Akao M AU - Matoba T AU - Nakamra M AU - Miyauchi K AU - Hagiwara N AU - Kimura K AU - Hirayama A AU - Matsui K AU - Ogawa H PY - 2021 JO - Heart (British Cardiac Society) DO - 10.1136/heartjnl-2021-319321 UR - https://doi.org/10.1136/heartjnl-2021-319321 ER -
APA
H, F., J, A., S, Y., K, K., M, A., T, M., M, N., K, M., N, H., K, K., A, H., K, M., & H, O. (2021). Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation.. Heart (British Cardiac Society). https://doi.org/10.1136/heartjnl-2021-319321
Source records
- pubmed · retrieved 2026-09-26T18:57:23.010Z